THE URDU TRANSLATION AND VALIDATION OF FACT-COG VERSION 3 SCALE IN PAKISTANI BREAST CANCER SURVIVORS
Main Article Content
Abstract
Background: The Functional Assessment of Cancer Therapy-Cognitive Version3 (FACT-Cog V3) is a self-report instrument designed with a specific focus on quantifying the cognitive impairments experienced by individuals who have been diagnosed with cancer. The main aim of this study was to undertake the translation and adaptation of the original version 3 of FACT-Cog into the Urdu language, while also taking into account cross-cultural considerations.
Method: The research study employed a survey research design as its foundation. The researchers employed a purposive sampling technique to gather data from the medical records of female individuals who have survived breast cancer and fall within the age range of 21 to 50. These individuals received treatment at different hospitals located in Islamabad, Rawalpindi, and Lahore. The sample was collected on two occasions. Initially, a sample of 40 breast cancer survivors was collected for translation. Subsequently, a sample of 319 breast cancer survivors was collected to confirm and validate the factors of the translated version of the scale. All the required analyses were conducted using SPSS (Version 26) and AMOS (Version 23).
Main Findings: The study revealed noteworthy positive correlations (ranging from .82 to 90) between the FACT-Cog scores obtained in Urdu and those obtained in the English version. The scale demonstrated satisfactory alpha reliability, with a coefficient of 0.88. The final thirty-seven items of the Urdu version of the scale were validated through Confirmatory Factor Analysis.
Conclusion: The cross-cultural utility of the Pakistani adaptation of FACT-Cog (Version-3) has been substantiated through an examination of its psychometric properties in a sample of breast cancer survivors.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., Hanscom, B. S., ... & Kaufman, P. A. (2012). Cognitive function in breast cancer patients before adjuvant treatment. Breast cancer research and treatment, 135(1), 135-147.
Boelen, P. A., van den Hout, M. A., & van den Bout, J. (2008). The factor structure of posttraumatic stress disorder symptoms among bereaved individuals: A confirmatory factor analysis study. Journal of Anxiety Disorders, 22(8), 1377-1383.
Cheung YT, Lim SR, Shwe M, et al (2013) Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer. Value Health 16:1001–1013. doi: 10.1016/j.jval.2013.06.017
Chovanec M., Vasilkova L., Setteyova L., Obertova J., Palacka P., Rejlekova K., et al. (2018). Long‐Term Cognitive Functioning in Testicular Germ‐Cell Tumor Survivors. Oncol. 23 (5), 617–623. 10.1634/theoncologist.2017-0457
Dwek MR, Rixon L, Hurt C, et al: Is there a relationship between objectively measured cognitive changes in patients with solid tumors undergoing chemotherapy treatment and their health-related quality of life outcomes? A systematic review. Psychooncology 26:1422-1432, 2017
Dyk, K. V., Crespi, C. M., Petersen, L., & Ganz, P. A. (2019). Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment. JNCIcancerspectrum, 4(1),pkz099. https://doi.org/10.1093/jncics/pkz099
Harvey, P. D. (2022). Domains of cognition and their assessment. Dialogues in clinical neuroscience.
Hajj, A., Salameh, P., Khoury, R., Hachem, R., Sacre, H., Chahine, G., ... & Khabbaz, L. (2020). Psychometric Properties of the 37-item Functional Assessment of Cancer Therapy-Cognitive Function (FACT-Cog) scale in Cancer Patients.
Hoekstra, R., Vugteveen, J., Warrens, M. J., & Kruyen, P. M. (2019). An empirical analysis of alleged misunderstandings of coefficient alpha. International Journal of Social Research Methodology, 22(4), 351-364.
Horowitz T. S., Suls J., Treviño M. (2018). A Call for a Neuroscience Approach to Cancer-Related Cognitive Impairment. Trends Neurosciences 41 (8), 493–496.
10.1016/j.tins.2018.05.001.
Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011, June). An update on cancer-and chemotherapy-related cognitive dysfunction: current status. In Seminars in oncology (Vol. 38, No. 3, pp. 431-438). WB Saunders.
Joly F, LangeM, Rigal O, et al (2012) French version of the functional assessment of cancer therapy-cognitive function (FACT-Cog) version 3. Support Care Cancer 20:3297–3305. doi:10.1007/s00520-012-1439-2
Kline, T. J. (2017). Sample issues, methodological implications, and best practices. Canadian Journal of Behavioural Science/Revue canadienne des sciences ducomportement, 49(2), 71.
Lange, M., & Joly, F. (2017). How to identify and manage cognitive dysfunction after breast cancer treatment. Journal of Oncology Practice, 13(12), 784-790.
Kim H., Jung S., Kim H., Abraham I. Systematic review of longitudinal studies on chemotherapy-associated subjective cognitive impairment in cancer patients. Psycho-Oncology. 2020;29:617–631. doi: 10.1002/pon.5339.
Myers, J. S. (2013, November). Cancer-and chemotherapy-related cognitive changes: the patient experience. In Seminars in oncology nursing (Vol. 29, No. 4, pp. 300-307).
WB Saunders.Országhová, Z., Mego, M., & Chovanec, M. (2021). Long-term cognitive dysfunction in cancer survivors. Frontiers in molecular biosciences, 8, 770413.
Park, J. H., Bae, S. H., Jung, Y. S., & Jung, Y. M. (2015). The psychometric properties of the Korean version of the functional assessment of cancer therapy-cognitive (FACT-Cog) in Korean patients with breast cancer. Supportive Care in Cancer, 23, 2695-2703.
Schmidt, John E.; Beckjord, Ellen; Bovbjerg, Dana H.; Low, Carissa A.; Posluszny, Donna M.; Lowery, Amy E.; Dew, Mary Amanda; Nutt, Stephanie; Arvey, Sarah R.; Rechis, Ruth (2016). Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey. Journal of Cancer Survivorship, 10(2), 302–311. doi:10.1007/s11764-015-0476-5
Sürücü, L., & Maslakci, A. (2020). Validity and reliability in quantitative research. Business & Management Studies: An International Journal, 8(3), 2694-2726. Tyupa, S. (2011).
A theoretical framework for back-translation as a quality assessment tool. New Voices in Translation Studies, 7(1), 35-46.
Von Ah D., Habermann B., Carpenter J.S., Schneider B.L. Impact of perceived cognitive impairment in breast cancer survivors. Eur. J. Oncol. Nurs. 2013;17:236–241. doi: 10.1016/j.ejon.2012.06.002
Von Ah D., Tallman E.F. Perceived Cognitive Function in Breast Cancer Survivors: Evaluating Relationships With Objective Cognitive Performance and Other Symptoms Using the Functional Assessment of Cancer Therapy—Cognitive Function Instrument. J.PainSympt.Manag. 2015;49:697–706 doi: 10.1016/j.jpainsymman.2014.08.012
Wagner L, Sweet J, Butt Z et al (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy—cognitive function instrument. J Support Oncol 7:W32–W39.
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value in health, 8(2), 94-104.